切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 熱門媒體

熱門媒體
(
  • 最新
)

熱門媒體

(
  • 最新
)
PD07-6: Could a single implant in the corpus cavernosum be sustainable?
800 觀看
PD06-3: Inhibition of LGALS1 Enhances ENZ Sensitivity in AR-Expressing Prostate Cancer Cells by Suppressing Energy Metabolism
800 觀看
NDP38: Ultramini ECIRS for a 3.7cm staghorn stone in a patient with horseshoe kidney and ileal conduit: A case report
800 觀看
NDP62: Retrograde intrarenal surgery for a giant para-pelvic cyst: A case report
800 觀看
(MP3-08) Study on sesamin inhibiting malignant progression of human bladder tumor
797 觀看
(MP4-02) A Meta-analysis and Systematic Review of the Correlation between the Outcome of Urolithiasis and High-dose Vitamin D supplementation
797 觀看
NDP13: Well-differentiated papillary mesothelial tumor, a rare para-testicular tumor -- case report
797 觀看
(MP1-03) Public Chinese Prostate Cancer Professional Series-3:Updated Treatment for metastatic Castration-Resistant Prostate Cancer (mCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
795 觀看
(MP1-05) Public Chinese Prostate Cancer Professional Series-3:Updated Treatment for non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
795 觀看
PD01-02: Knockdown of EPS8 expression may attenuate disease progression in enzalutamide-resistant prostate cancer
795 觀看
(MP01-02) Testosterone breakthrough rates during androgen deprivation therapy for castration sensitive prostate cancer
795 觀看
NDP29: Poorly differentiated urothelial carcinoma of the urachus: A case report
795 觀看
PD08-1: Cryoablation for Renal Angiomyolipoma: Analysis of Efficacy and Complication
793 觀看
NPD17: Case Report: Adrenal Schwannoma
791 觀看
PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
791 觀看
PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
791 觀看
NDP17: Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with repeated acute urine retention
791 觀看
NDP19: Aggressive prostate cancer mimicking urothelial carcinoma: A case report
791 觀看
PD09-3: The incidence and multiplex nomogram for prediction of metachronous and synchronous upper tract urothelial cancer in patients with non-muscle invasive urinary bladder cancer
790 觀看
NDP08: Bladder outlet obstruction caused by cystitis cystica et glandularis at bladder neck
790 觀看
(MP3-05) High Incidence of Upgrading between Ureterorenoscopic Biopsy and Final Pathology in Upper Tract Urothelial Carcinoma: A Single Regional Hospital Experience
789 觀看
NPD73: Skene’s Duct Cyst: An Uncommon Cause of Female Bladder Outlet Obstruction
789 觀看
(MP3-06) Real-world outcome of endoscopic laser ablation for upper urinary tract urothelial carcinoma
788 觀看
PD01-3: Complication Analysis of Transurethral Resection of Prostate Under Different Types of Anesthesia: A Nationwide, Population-based Cohort Study
788 觀看
  • <
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • >
/ 127
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw